Enliven Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
/ 
Frequently asked questions
To buy Enliven Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Enliven Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Enliven Therapeutics Inc. is ELVN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Enliven Therapeutics Inc. has its primary listing on NASDAQ. You can trade Enliven Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Enliven Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Enliven Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Enliven Therapeutics Inc..